Learn more at LeadIQ.com

Insights

Cutting-Edge Technology CRISPR Therapeutics utilizes the revolutionary CRISPR/Cas9 gene editing technology to develop precise and transformative gene-based medicines, positioning itself as a leader in the biotechnology research industry.

Collaborative Ventures CRISPR Therapeutics has established strategic collaborations with major companies like Bayer, Vertex Pharmaceuticals, and ViaCyte, presenting opportunities for cross-selling and joint ventures to leverage combined resources and expertise in the market.

Financial Growth Potential With a revenue in the range of $50M - $100M and funding worth $280M, CRISPR Therapeutics demonstrates financial stability and growth potential, making them an attractive partner for investment and partnership deals.

Product Diversification The company has a diverse portfolio of therapeutic programs covering various disease areas such as hemoglobinopathies, oncology, regenerative medicine, and rare diseases, offering a wide range of solutions for potential clients and partners across different healthcare sectors.

Upcoming Human Trials CRISPR Therapeutics is set to launch human trials testing their innovative therapy CTX450 in 2025, presenting a timing-based sales opportunity for healthcare providers and pharmaceutical companies interested in cutting-edge clinical trials and treatments.

Similar companies to CRISPR Therapeutics

CRISPR Therapeutics Tech Stack

CRISPR Therapeutics uses 8 technology products and services including Qubit, Docker, Craft CMS, and more. Explore CRISPR Therapeutics's tech stack below.

Qubit
A/B Testing
Docker
Containerization
Craft CMS
Content Management System
Oracle E-Business Suite
Enterprise Resource Planning
Veeva Systems
IT Infrastructure & Operations Management
jQuery
Javascript Libraries
Boomi
Platform As A Service
Linux
Programming Languages

Media & News

CRISPR Therapeutics's Email Address Formats

CRISPR Therapeutics uses at least 1 format(s):

CRISPR Therapeutics Email Formats	Example	Percentage
First.Last@crisprtx.com	John.Doe@crisprtx.com	89%
FLast@crisprtx.com	JDoe@crisprtx.com	8%
Last@crisprtx.com	Doe@crisprtx.com	2%
F.Last@crisprtx.com	J.Doe@crisprtx.com	1%

Frequently Asked Questions

Where is CRISPR Therapeutics's headquarters located?

CRISPR Therapeutics's main headquarters is located at 105 West First Street Boston, MA 02127 US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is CRISPR Therapeutics's phone number?

You can contact CRISPR Therapeutics's main corporate office by phone at

+41-61-228-7****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CRISPR Therapeutics's stock symbol?

CRISPR Therapeutics is a publicly traded company; the company's stock symbol is CRSP.

What is CRISPR Therapeutics's official website and social media links?

CRISPR Therapeutics's official website is crisprtx.com and has social profiles on LinkedIn.

How much revenue does CRISPR Therapeutics generate?

As of November 2024, CRISPR Therapeutics's annual revenue reached $75M.

What is CRISPR Therapeutics's SIC code NAICS code?

CRISPR Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CRISPR Therapeutics have currently?

As of November 2024, CRISPR Therapeutics has approximately 436 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: S. K.Chief Financial Officer: R. P.Chief Operating Officer: J. B.. Explore CRISPR Therapeutics's employee directory with LeadIQ.

What industry does CRISPR Therapeutics belong to?

CRISPR Therapeutics operates in the Biotechnology Research industry.

What technology does CRISPR Therapeutics use?

CRISPR Therapeutics's tech stack includes QubitDockerCraft CMSOracle E-Business SuiteVeeva SystemsjQueryBoomiLinux.

What is CRISPR Therapeutics's email format?

CRISPR Therapeutics's email format typically follows the pattern of . Find more CRISPR Therapeutics email formats with LeadIQ.

How much funding has CRISPR Therapeutics raised to date?

As of November 2024, CRISPR Therapeutics has raised $280M in funding. The last funding round occurred on Feb 13, 2024 for $280M.

When was CRISPR Therapeutics founded?

CRISPR Therapeutics was founded in 2013.

CRISPR Therapeutics

CRISPR Therapeutics

Biotechnology ResearchMassachusetts, United States201-500 Employees

CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom.

Company Overview

Headquarters: 105 West First Street Boston, MA 02127 US
Phone number: +41-61-228-7****
Website: crisprtx.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: CRSP
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2013
Employees: 201-500

Media & News

Funding & Financials

$280M
CRISPR Therapeutics has raised a total of $280M of funding over 6 rounds. Their latest funding round was raised on Feb 13, 2024 in the amount of $280M.
$50M$100M
CRISPR Therapeutics's revenue is in the range of $50M$100M

Funding & Financials

$280M
CRISPR Therapeutics has raised a total of $280M of funding over 6 rounds. Their latest funding round was raised on Feb 13, 2024 in the amount of $280M.
$50M$100M
CRISPR Therapeutics's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.